XML 23 R6.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (12,440,023) $ (831,486)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 10,001,359 199,556
Gain on legal settlements   (150,000)
Changes in operating assets and liabilities:    
Research and development tax credit receivable (485,349) (38,000)
Other tax receivable 74,236 (76,379)
Joint development cost receivable 91,135 47,257
Prepaid expenses 27,095 (39,647)
Prepaid expenses - related party 158,504 (112,042)
Accounts payable and accrued liabilities 688,489 68,548
Accounts payable and accrued liabilities - related parties (174,440) 170,359
Net cash used in operating activities (2,058,994) (761,834)
CASH FLOWS FROM INVESTING ACTIVITIES    
Cash paid for acquired in-process research and development intangible assets   (100,000)
Net cash used in investing activities   (100,000)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Net proceeds from sale of common stock 900,000 2,056,000
Net cash provided by financing activities 900,000 2,056,000
Impact on cash from foreign currency translation (25,513) 34,886
NET INCREASE (DECREASE) IN CASH (1,184,507) 1,229,052
CASH AT BEGINNING OF YEAR 1,370,711 141,659
CASH AT END OF YEAR 186,204 1,370,711
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:    
Cash paid for income taxes 0 0
Cash paid for interest expense $ 0 0
NONCASH INVESTING AND FINANCING ACTIVITIES:    
Issuance of common stock and warrants for acquired in-process research and development intangible asset   16,414,000
Conversion of related party debt to common stock   350,000
Issuance of common stock for settlement of accounts payable   $ 30,000